... III trials on NSCLC by Breathnach and Freidlin [17] between 1973 and 1994 ...updated clinical practice guidelines of the American Society of Clinical Oncology on chemotherapy for Stage IV non- small- ...
... and maintenance of these disorders [15]. Thus, by focusing on treating these processes rather than disorder-specific variations, larger and more lasting effects on clinical outcomes would be expected [13]. These ...
... one trials (31%) DVT diagnosis was triggered by clinical suspicion; the remaining trials either screened for DVT or were unclear about their ...(16%) trials respectively reported on major ...
... A total of 9771 studies were identified through data bases search, 22 duplicates were removed and 9749 of them were screened through title and abstract; of these, only 64 were selected for eligibility; at last 7 studies ...
... improved clinical outcomes. Future trials should include histological out- comes with longer duration of treatment and follow-up to determine whether or not our current proposed theories of the treatment of ...
... The authors (LMCG and RCS) conducted a review of the articles registered in PUBMED, SCIELO, and EBSCOHOST published in English and Spanish with the following search data: «1999/01/01»: «2008/12/31» and «Obesity ...
... placebo-controlledrandomizedclinicaltrials designed to examine the pharmacotherapy, and not the whole program of behavior therapy and pharmacotherapy 6 ...these trials, with only a ...
... 12 only Rao et al. (2009) identified their study as a pilot study. Both studies were randomized and double-blinded. They included 4 groups (2 intervention and 2 control). Although the study of Groeger and ...
... Twelve subjects with mean age 58.9 ± 6.2 years were enrolled and randomized, six in the PTX + AMO arm and six in the placebo + AMO arm (Figure 2). Overall cohort mean MELD score was 26.5 ± 7.4 and all subjects had ...
... and fifty-one patients with histology-proven advan- ced fibrosis or early cirrhosis were randomized to receive lamivudine (n = 436) or placebo (n = 215). At a median follow-up of 32 months, disease progre- ssion, ...
... For severe diarrhea, as in the case described, I typically recommend starting a low daily dose of loperamide (2 to 4 mg every morning, noting that this can be increased if the patient has a particularly important ...
... Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Aliment P[r] ...
... Various studies have suggested a link between severe periodontitis, the prevalence of Porphyromonas gingivalis, and the development of rheumatoid arthritis. As evidence of this relationship, P. gingivalis has been found ...
... Impaired muscle function and cancer-related fatigue (CRF) are two of the most common complications among patients in additiounder chemotherapy [3]. Moreover, early, localized muscular fatigue and severe decondition- ing ...
... meta-analyses, controlledclinicaltrials, analytical (cases and controls, and cohorts), and non- analytical (prevalence) with diagnosis of CD and DS with keywords in English (celiac disease and Down ...
... perinatal clinical record), and 4) omission of the medical analyses demanded by the ...CoMPAS clinical trial had been approved by two private ethics committees (although only one of them ended up being ...
... of clinicaltrials will receive a favourable deci- sion at first evaluation by the ECCRs, without any need for clarifications or ...oncological clinicaltrials will be due to faults in Patient ...
... II data set demonstrated that both within the panel agreement and be- tween the panel and local pathologists agreement decreased with in- creasing category of severity of rejection grade (from 65% to 28%). 10 In that ...